Integra Connect

Come visit Integra PrecisionQ at the San Antonio Breast Cancer Symposium (SABCS 2024) for our (7) poster sessions on December 11th and 12th, 2024. Integra PrecisionQ presenters and authors are: Anupama Vasudevan | Pinyao Anna Rui | Dawn Smith Brenneman | Michael Gart | Brandon Wang | Prateesh Varughese PharmD MBA | Erin Alwon | Jeffrey Scott | Teena Sura | Harshal Dave | Douglas Kanovsky | Lindsay (Gingras) Aton | Lisa Morere. #SABCS2024 | #IntegraConnect

Your oncology patients and their caregivers need between-visit care and support. (Care that your clinical staff is likely providing for free.) Chronic Care Management can provide high-quality, proactive between-visit care for all your eligible patients while supporting outcomes in Advanced Payment Models and providing revenue that can sustain practice operations. Join Integra Connect, Phamily and Sweeten Health this week to learn more in a Live Webinar and Q&A on November 21st at 4:00 PM EST / 1:00 PM PST. Register now to secure your spot: https://lnkd.in/eacHtput

We extend our heartfelt gratitude to all of our Armed Forces Veterans. Your bravery, dedication, and sacrifices have helped shape the strength of our nation.

While at the American Society of Hematology Conference in San Diego (ASH), come see Integra Connect PrecisionQ’s Poster Presentation #2353 on Saturday, December 7th, 5:30PM -7:30PM PST. Presenting our study on “Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Utilization and Clinical Outcomes Among Patients with Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)”. Link:?https://lnkd.in/eBfpdCXd Anupama Vasudevan | Pinyao Anna Rui | Brandon Wang | Prateesh Varughese PharmD MBA | Michael Gart | #ASH24 |?#CLL?|?#BTKi

While at the American Society of Hematology Conference in San Diego (ASH), come see Integra Connect PrecisionQ’s Poster Presentation #3253 on Sunday, December 8th, 6:00PM – 8:00PM PST. Presenting our study on “Treatment-Emergent Cardiovascular Events Among Patients with Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) treated with Bruton’s Tyrosine Kinase Inhibitors (BTKI)”. Link: ?https://lnkd.in/etS5JsJU Anupama Vasudevan | Pinyao Anna Rui | Michael Gart | Brandon Wang | Prateesh Varughese PharmD MBA | Poras Dave #ASH24?|?#CLL?|?#BTKi

?? Exciting News! Integra Connect is thrilled to announce our partnership with Phamily and Sweeten Health! ?? ? With this collaboration, we're empowering our network of practices to deliver more consistent and proactive care for cancer patients. This means fewer unnecessary emergency department visits and inpatient stays, ultimately leading to better outcomes and more sustainable operations for our practices. ? As Jeffrey Scott, our Chief Medical Officer, states: “This partnership will transform the way we care for our patients, ensuring they receive the support they need between visits.” ? Curious to learn more? Check out the full details of our announcement here: https://lnkd.in/ee6a5ptu #Oncology #OncologyNews #ChronicCareManagement #AVBCC #ValueBasedCare #Cancer

Come check out one of Integra Connect PrecisionQ's poster presentations at the ASCO Quality Care Symposium at the Marriott Marque in San Francisco, today Friday, Sept., 27th from 11:30A - 1:00P & 5:30P - 6:30P PST. This poster presents: A quality initiative focused on BRCA and HRD testing and use of first line maintenance in advanced ovarian cancer. This quality initiative resulted in an increase in HRD testing (41% to 73%), BRCA testing (86% to 96%), and use of 1st line maintenance (57% to 88%). Poster E26 | Abstract 286 Link: https://lnkd.in/eaXhNvFJ Authors:?Michael Gart | Teena Sura | Anupama Vasudevan | Douglas Kanovsky | Prateesh Varughese PharmD MBA | Simon Blanc MD

Come check out one of Integra Connect PrecisionQ’s poster presentations at the ASCO Quality Care Symposium,?at the Marriott Marque in San Francisco, today, Sept 27th from 11:30A – 1:00P & 5:30P – 6:30P PST. The poster will present: A quality initiative in BRCA testing and timing of BRCA test prior to Surgery in HER2- early-stage breast cancer. This quality initiative focused on BRCA testing among HER2 – BC pts led to an improvement from 44% to 56% of pts being tested.?Among those who were tested, there was an increase from 58% to 80% tested prior to surgery. Poster F1 | Abstract 287 Link: https://lnkd.in/eH2Dr4pd Authors:??Vikram C. Gorantla | Michael Gart | Teena Sura | Douglas Kanovsky | Anupama Vasudevan | Prateesh Varughese PharmD MBA | Simon Blanc MD | Rushir J. Choksi, MD #ASCOQLTY24

Today we announced our Distinguished Innovators (DI) Program. This annual initiative is dedicated to recognizing and rewarding the exceptional talent within Integra Connect. ? This program identifies, recognizes, and promotes innovative thought leaders who also possess exemplary guiding principles and a high-performance mindset, aligned with Integra’s core values. The program encourages diversity of thought within the company, serving as an innovation catalyst that solves an operational or technical challenge facing our customers, the company, or our industry. ? The DI Program provides Subject Matter Experts in their respective fields a unique opportunity to help establish a culture of continuous innovation and operational excellence by tackling difficult problems, developing innovative solutions, and advising senior leadership on progressive technology, ideas, and process improvements. ? The "Distinguished" honor recognizes a select group of accomplished innovators each year who consistently lead, perform, inspire, and contribute at an elite level. ? DI's will be selected through peer nominations, and a combination of peer & senior leadership voting. Up to 5 individuals will be selected for the designation each year and will hold the title for 2 years. ? Awards include but are not limited to a monetary award & education dollars. ? We thank all our employees for your hard work & dedication and look forward to recognizing your exemplary achievements.

One of the biggest differentiators at Integra Connect is our People! Get to know the talented individuals who provide outstanding support to our business day in and day out. As part of our #peoplebehindtheproduct program, meet Robin Tardif. Robin works as a Lead Clinical Terminologist.